Stephen L. Rawlings

Array ( [id] => 5302786 [patent_doc_number] => 20090297438 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'Human Monoclonal Antibodies to Prostate Specific Membrane Antigen (PSMA)' [patent_app_type] => utility [patent_app_number] => 11/918153 [patent_app_country] => US [patent_app_date] => 2006-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 34744 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20090297438.pdf [firstpage_image] =>[orig_patent_app_number] => 11918153 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4537136 [patent_doc_number] => 07875278 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-25 [patent_title] => 'Monoclonal antibodies against prostate specific membrane antigen (PSMA) lacking in fucosyl residues' [patent_app_type] => utility [patent_app_number] => 11/918191 [patent_app_country] => US [patent_app_date] => 2006-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 25 [patent_no_of_words] => 34737 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/875/07875278.pdf [firstpage_image] =>[orig_patent_app_number] => 11918191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6038440 [patent_doc_number] => 20110091489 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'SURVIVIN PEPTIDE VACCINE' [patent_app_type] => utility [patent_app_number] => 11/815631 [patent_app_country] => US [patent_app_date] => 2006-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 23128 [patent_no_of_claims] => 78 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20110091489.pdf [firstpage_image] =>[orig_patent_app_number] => 11815631 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5694721 [patent_doc_number] => 20060154868 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis' [patent_app_type] => utility [patent_app_number] => 11/347115 [patent_app_country] => US [patent_app_date] => 2006-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8958 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20060154868.pdf [firstpage_image] =>[orig_patent_app_number] => 11347115 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5284371 [patent_doc_number] => 20090098046 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'Combination Cancer Therapy with Anti-PSMA Antibodies' [patent_app_type] => utility [patent_app_number] => 11/795268 [patent_app_country] => US [patent_app_date] => 2006-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13327 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20090098046.pdf [firstpage_image] =>[orig_patent_app_number] => 11795268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5618907 [patent_doc_number] => 20060188440 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-24 [patent_title] => 'Anti-mullerian inhibiting substance type II receptor (MISIIR) immunoconjugates to detect and treat cancer' [patent_app_type] => utility [patent_app_number] => 11/327917 [patent_app_country] => US [patent_app_date] => 2006-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 16110 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20060188440.pdf [firstpage_image] =>[orig_patent_app_number] => 11327917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5595778 [patent_doc_number] => 20060159694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Combinations of tumor-associated antigens in compositions for various types of cancers' [patent_app_type] => utility [patent_app_number] => 11/323049 [patent_app_country] => US [patent_app_date] => 2005-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 23610 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20060159694.pdf [firstpage_image] =>[orig_patent_app_number] => 11323049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5199687 [patent_doc_number] => 20070299005 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-27 [patent_title] => 'Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/298315 [patent_app_country] => US [patent_app_date] => 2005-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 14439 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20070299005.pdf [firstpage_image] =>[orig_patent_app_number] => 11298315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4455583 [patent_doc_number] => 07892827 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-22 [patent_title] => 'Compound with affinity for the cytotoxic T lymphocyte-associated antigen (CTLA-4)' [patent_app_type] => utility [patent_app_number] => 11/720234 [patent_app_country] => US [patent_app_date] => 2005-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 31 [patent_no_of_words] => 36546 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/892/07892827.pdf [firstpage_image] =>[orig_patent_app_number] => 11720234 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5648936 [patent_doc_number] => 20060134668 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Methods for treating patients and identifying therapeutics' [patent_app_type] => utility [patent_app_number] => 11/274634 [patent_app_country] => US [patent_app_date] => 2005-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 29213 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20060134668.pdf [firstpage_image] =>[orig_patent_app_number] => 11274634 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5799313 [patent_doc_number] => 20060034844 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Stimulation of T cells against self antigens using CTLA-4 blocking agents' [patent_app_type] => utility [patent_app_number] => 11/241615 [patent_app_country] => US [patent_app_date] => 2005-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 22789 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20060034844.pdf [firstpage_image] =>[orig_patent_app_number] => 11241615 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6174323 [patent_doc_number] => 20110177079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'Cancer-testis antigens' [patent_app_type] => utility [patent_app_number] => 11/662322 [patent_app_country] => US [patent_app_date] => 2005-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 32697 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 32 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20110177079.pdf [firstpage_image] =>[orig_patent_app_number] => 11662322 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4879272 [patent_doc_number] => 20080152655 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-26 [patent_title] => 'Combination Therapy With Anti-Ctla4 and Anti-4-1BB Antibodies' [patent_app_type] => utility [patent_app_number] => 10/536115 [patent_app_country] => US [patent_app_date] => 2005-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7195 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20080152655.pdf [firstpage_image] =>[orig_patent_app_number] => 10536115 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7069035 [patent_doc_number] => 20050244418 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Recombinant tumor specific antibody and use thereof' [patent_app_type] => utility [patent_app_number] => 11/174186 [patent_app_country] => US [patent_app_date] => 2005-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14755 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20050244418.pdf [firstpage_image] =>[orig_patent_app_number] => 11174186 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7217023 [patent_doc_number] => 20050260234 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Anti-neovasculature preparations for cancer' [patent_app_type] => utility [patent_app_number] => 11/073347 [patent_app_country] => US [patent_app_date] => 2005-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12998 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20050260234.pdf [firstpage_image] =>[orig_patent_app_number] => 11073347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5732832 [patent_doc_number] => 20060257949 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Methods of diagnosing and treating brain tumors' [patent_app_type] => utility [patent_app_number] => 11/166894 [patent_app_country] => US [patent_app_date] => 2005-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16449 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20060257949.pdf [firstpage_image] =>[orig_patent_app_number] => 11166894 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5125441 [patent_doc_number] => 20070237712 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-11 [patent_title] => 'Methods of Redistributing Apical Target Antigens to Detect and Treat Cellular Proliferative Disease' [patent_app_type] => utility [patent_app_number] => 11/628877 [patent_app_country] => US [patent_app_date] => 2005-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13737 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20070237712.pdf [firstpage_image] =>[orig_patent_app_number] => 11628877 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6588876 [patent_doc_number] => 20100062001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'Antibodies for selective apoptosis of cells' [patent_app_type] => utility [patent_app_number] => 11/629194 [patent_app_country] => US [patent_app_date] => 2005-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 23514 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20100062001.pdf [firstpage_image] =>[orig_patent_app_number] => 11629194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6966035 [patent_doc_number] => 20050232932 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Compositions and methods for dendritic cell-based immunotherapy' [patent_app_type] => utility [patent_app_number] => 11/144912 [patent_app_country] => US [patent_app_date] => 2005-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14067 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20050232932.pdf [firstpage_image] =>[orig_patent_app_number] => 11144912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 520188 [patent_doc_number] => 07189823 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-03-13 [patent_title] => 'Antibody against illfdyfnr' [patent_app_type] => utility [patent_app_number] => 11/133177 [patent_app_country] => US [patent_app_date] => 2005-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12688 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/189/07189823.pdf [firstpage_image] =>[orig_patent_app_number] => 11133177 [rel_patent_id] =>[rel_patent_doc_number] =>)